FDA un­veils new rare dis­ease pi­lot pro­gram to in­crease agency-spon­sor com­mu­ni­ca­tions

The FDA on Fri­day un­veiled new de­tails around a rare dis­ease pi­lot pro­gram that seeks to in­crease rapid, ad-hoc com­mu­ni­ca­tions be­tween six spon­sors work­ing on such treat­ments and the agency.

Be­tween Jan. 2, 2024 and March 1, 2024, pi­lot pro­gram par­tic­i­pants will be se­lect­ed based on ap­pli­ca­tion readi­ness (e.g., spon­sors who can move their de­vel­op­ment pro­grams for­ward more quick­ly), with up to three par­tic­i­pants for each cen­ter.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER